Research shows the peptide called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases
Summary of European Society of Cardiology report will direct both heart and kidney failure specialists to make best use of new treatments and prolong lives.
JMCC PLUS publishes fundamental and translational research that advances knowledge of the mechanisms for normal and diseased cardiovascular function.
Researchers who identified a novel mechanism for platelet activation in blood clotting (thrombosis) are now turning their attention to sepsis
Patients, parents, charities and healthcare professionals agree key focuses for future research for disease affecting around half a million in UK
A new study, conducted by the Atrial Fibrillation NETwork (AFNET), offered smartphone and arrhythmia screening to older adults without atrial fibrillation.
New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
Dr Gill Lowe in the Institute of Cardiovascular Sciences, University of Birmingham has been appointed National Haematology Specialty Lead
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases